tiprankstipranks
CellSource Co. Announces Major Forecast Revisions
Company Announcements

CellSource Co. Announces Major Forecast Revisions

CellSource Co., Ltd. (JP:4880) has released an update.

Don't Miss our Black Friday Offers:

CellSource Co., Ltd. has announced significant downward revisions to its full-year financial forecasts for fiscal year 2024, citing a decrease in contracts for its stem cell processing services, particularly from medical institutions with self-funded treatments. The company’s revised forecast anticipates decreases in net sales, operating profit, ordinary profit, and profit earnings per share, with overall changes ranging from -18.5% to -58.1%. Despite a partial increase in non-operating income from a government subsidy, the reduction in contracts and operating profit has led to these adjustments.

For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App